- Home
- TARS vs INTR Comparison
TARS vs INTR Comparison
Compare TARS & INTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARS
- INTR
- Stock Information
- Founded
- TARS 2016
- INTR 1994
- Country
- TARS United States
- INTR Brazil
- Employees
- TARS N/A
- INTR 3270
- Industry
- TARS Medicinal Chemicals and Botanical Products
- INTR
- Sector
- TARS Health Care
- INTR
- Exchange
- TARS Nasdaq
- INTR Nasdaq
- Market Cap
- TARS 2.1B
- INTR 2.1B
- IPO Year
- TARS 2020
- INTR N/A
- Fundamental
- Price
- TARS $46.52
- INTR $4.73
- Analyst Decision
- TARS Strong Buy
- INTR Strong Buy
- Analyst Count
- TARS 5
- INTR 4
- Target Price
- TARS $54.20
- INTR $7.13
- AVG Volume (30 Days)
- TARS 735.2K
- INTR 1.9M
- Earning Date
- TARS 02-25-2025
- INTR 02-05-2025
- Dividend Yield
- TARS N/A
- INTR 2.54%
- EPS Growth
- TARS N/A
- INTR 295.93
- EPS
- TARS N/A
- INTR 0.33
- Revenue
- TARS $129,621,000.00
- INTR $767,729,562.00
- Revenue This Year
- TARS $917.88
- INTR N/A
- Revenue Next Year
- TARS $78.70
- INTR $23.65
- P/E Ratio
- TARS N/A
- INTR $14.16
- Revenue Growth
- TARS 801.96
- INTR 38.44
- 52 Week Low
- TARS $20.08
- INTR $3.88
- 52 Week High
- TARS $57.14
- INTR $7.84
- Technical
- Relative Strength Index (RSI)
- TARS 37.06
- INTR 56.92
- Support Level
- TARS $43.61
- INTR $4.20
- Resistance Level
- TARS $57.00
- INTR $4.44
- Average True Range (ATR)
- TARS 2.65
- INTR 0.13
- MACD
- TARS -1.27
- INTR 0.11
- Stochastic Oscillator
- TARS 21.51
- INTR 86.90
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About INTR Inter & Co. Inc.
Inter & Co Inc operates as a digital bank. The company's segment includes Banking & Spending; Investments; Insurance Brokerage; and Inter Shop & Commerce Plus. It generates maximum revenue from the Banking & Spending.